Market evolution: Medical endoscopes (CN 90189020) — 2015–2025

Introduction

This report analyses the evolution of EU trade in medical endoscopes (Combined Nomenclature code 90189020) over the period 2015–2025. Endoscopes are high-value medical devices used in minimally invasive diagnostics and surgery, and the EU—particularly Germany—is a major global producer and exporter. The data reveals a decade of strong growth, a decisive shift toward net-export status, and significant restructuring of supply chains, including the rapid emergence of Asian suppliers. The following sections examine these dynamics in detail.

1. A Decade of Rapid Growth and Strengthening Trade Surplus

EU trade in medical endoscopes expanded dramatically between 2015 and 2025

Over the period examined, EU exports of endoscopes grew by 138.3% in value, rising from €583.8 million to €1,391.3 million. In volume terms, export shipments increased by 165.3%, from 487.6 tonnes to 1,293.5 tonnes. Imports also grew, but at a slower pace: their value rose 79.1% (from €530.3 million to €949.6 million), and their volume increased 105.5% (from 1,024.3 tonnes to 2,105.0 tonnes). The asymmetry in growth rates produced a dramatic improvement in the EU's trade balance.

The EU trade surplus widened more than sevenfold

The net import reliance moved from –5.0% in 2015 to –170.2% in 2025, confirming that the EU has become a heavily net-exporting bloc in this product category. This is consistent with the EU's role as home to leading endoscope manufacturers, most notably in Germany.

Unit prices declined on both sides, suggesting commoditisation and competition

Despite strong value growth, average unit prices (EUR per tonne) fell on both the export and import sides:

Export prices remain roughly 2.4× higher than import prices, reflecting the premium positioning of EU-manufactured endoscopes. However, the decline in both price series points to increasing global competition, cost efficiencies in manufacturing, and the growing market share of lower-cost Asian producers.

2. Shifting Supply Chains: The Rise of Asian Sourcing

Japan remained the EU's dominant endoscope supplier throughout the decade

Japan has consistently been the largest single source of EU endoscope imports, accounting for flows that grew from €273.6 million to €376.1 million (+37.4%). This reflects the entrenched position of Japanese manufacturers such as Olympus, Fujifilm, and Hoya (Pentax), which dominate the global flexible endoscope market. Japan's supply relationship was also notably stable, with a volatility coefficient of just 0.25—the lowest among the EU's top import partners.

China and Malaysia emerged as fast-growing suppliers

Two Asian origins recorded extraordinary growth in EU-bound endoscope shipments over the period:

China's tenfold increase aligns with its broader strategy of moving up the value chain in medical devices, with companies such as Mindray and SonoScape expanding internationally. Malaysia's dramatic rise—from near-zero to €62.8 million—likely reflects the expansion of manufacturing or final-assembly operations by global firms (including Japanese companies) in Southeast Asia, a trend accelerated by supply-chain diversification strategies post-COVID.

Vietnamese imports collapsed, while Western suppliers grew steadily

Imports from Vietnam fell by 95.1%, from €8.8 million to just €0.4 million. This may indicate that early-stage production or transhipment activity did not mature, or that sourcing was redirected to other Asian origins. Meanwhile, imports from the United States (+89.9% to €168.6 M) and Switzerland (+55.0% to €175.0 M) continued to grow, reflecting the role of companies like Medtronic, Karl Storz, and other Western medtech firms.

The EU's import market became less concentrated

The Herfindahl–Hirschman Index (HHI) for imports by value fell from 3,417 to 2,337, a decline of 31.6%. While the market remains moderately concentrated, the reduction reflects the diversification away from Japan-centric sourcing toward China, Malaysia, and other origins—a structural shift that reduces single-supplier risk but introduces new dependencies.

3. EU Export Strength: A Germany-Driven, US-Focused Trade Pattern

Germany dominated EU endoscope production and exports

Germany accounted for 57.8% of EU production value in 2025, making it the undisputed centre of the EU endoscope industry. Germany's exports grew from €527.6 million to €1,077.6 million (+104.3%), while its imports rose more modestly from €444.2 million to €674.8 million (+51.9%). This underlines Germany's role as both a major manufacturer (Karl Storz, among others) and a processing hub that re-exports finished goods.

The Netherlands and Ireland emerged as increasingly significant EU exporters

Beyond Germany, several EU member states saw outsized export growth:

The Netherlands' growth may partly reflect its role as a logistics and distribution hub, but the strong performance of Ireland and the Baltic states (Estonia, Latvia) suggests that smaller EU economies are also developing niche capabilities in medical device assembly or re-export. The specialisation indices confirm that Estonia (RSCA 0.79) and Latvia (RSCA 0.57) are highly specialised in this product relative to their overall export baskets.

The United States was the EU's largest and fastest-growing export destination

EU exports to the United States grew from €234.5 million to €586.7 million (+150.2%), making it by far the largest single destination. The United Kingdom was the second-largest growth story, with exports rising 361.9% to €150.5 million—a surge likely reflecting post-Brexit trade reorientation and continued UK demand for high-end European medical equipment. Exports to Russia grew to a peak of €117.5 million before settling at €80.3 million in 2025, potentially reflecting geopolitical sanctions effects.

EU production volumes and values expanded substantially

EU production value grew from €231 million to €784.9 million (+239.8%), while production quantities surged from approximately 340,000 units to 6,000,000 units. The enormous jump in unit counts, combined with a more moderate rise in value, suggests that a significant portion of the growth came from lower-value or reusable endoscope accessories and components, in addition to premium rigid and flexible endoscopes.

Conclusion

The EU medical endoscope market underwent profound structural change between 2015 and 2025. The bloc consolidated its position as a major net exporter, with the trade surplus widening more than sevenfold to over €440 million, driven primarily by German production and surging demand from the United States and United Kingdom. At the same time, the EU's import landscape was reshaped by the rapid entry of Chinese and Malaysian suppliers, which diversified sourcing away from Japan while exerting downward pressure on import prices. These trends—premium export growth, Asian supply-chain diversification, and declining unit prices—point to a maturing global market in which the EU retains a competitive advantage in high-end manufacturing but faces intensifying competition from cost-efficient Asian producers. Monitoring supply concentration and geopolitical risk, particularly in light of evolving trade relationships with Russia and China, will be important for policymakers and industry stakeholders in the years ahead.